Cocaine addiction presents a significant challenge in treatment, as there are currently no FDA-approved medications specifically for its management. However, various pharmacotherapies are being explored to mitigate cravings and reduce relapse rates. Medications such as antidepressants, dopamine agonists, and anti-anxiety drugs can be used to treat the underlying neurochemical imbalances associated with cocaine addiction. Behavioral therapies, such as cognitive-behavioral therapy (CBT), are often integrated with pharmacological interventions to address the psychological components of addiction. Combining pharmacotherapy with psychosocial treatments has shown promise in improving long-term recovery outcomes for individuals with cocaine addiction.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : The Storm Within: Neuropsychological Insights into Dysregulation and Substance Use in the Adolescent Brain.
Ann Marie Leonard Zabel, Curry College, United States
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, CIAPS, Cambridge, United Kingdom
Title : Creative exploration of the complexity of the pre-lapse experience in the addict to add retrospective insight
Eric A Kreuter, Cornerstone of Rhinebeck, United States
Title : Resilience in counseling: Processing grief for the addictions counselor
Jorja Jamison, Hazelden Betty Ford Graduate School, United States
Title : Resilience in counseling: Processing grief for the addictions counselor
Kayla Albers, Hazelden Betty Ford Graduate School, United States